Invention Grant
- Patent Title: Poxviral oncolytic vectors
- Patent Title (中): 痘病毒溶瘤载体
-
Application No.: US12743407Application Date: 2008-11-17
-
Publication No.: US08778328B2Publication Date: 2014-07-15
- Inventor: Philippe Erbs , Johann Foloppe
- Applicant: Philippe Erbs , Johann Foloppe
- Applicant Address: FR Illkirch
- Assignee: Transgene S.A.
- Current Assignee: Transgene S.A.
- Current Assignee Address: FR Illkirch
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: EP07301557 20071119
- International Application: PCT/EP2008/009720 WO 20081117
- International Announcement: WO2009/065546 WO 20090528
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K39/275 ; A61K39/285 ; C12N7/01 ; C12N15/863
Abstract:
A poxvirus other than NYVAC but comprising a defective F4L and/or I4L gene and compositions comprising such poxvirus are useful for therapeutic purposes, and more particularly for the treatment of cancer.
Public/Granted literature
- US20110059049A1 POXVIRAL ONCOLYTIC VECTORS Public/Granted day:2011-03-10
Information query
